Fatty Acid Desaturase Gene Locus Interactions With Diet (FADSDIET2)
FADSDIET2
1 other identifier
interventional
140
1 country
1
Brief Summary
Interactions between genes and environment, are likely to be crucial in the development of the common diseases such as type 2 diabetes. Recently, the investigators have obtained data that genotypes of genes encoding for fatty acid desaturases 1 and 2 (FADS1 and FADS2) are the strongest genes in a genome-wide analysis regulating serum fatty acid profile.The aim of this study is to test if subjects with different genotypes of the FADS2 gene respond differently to a diet supplemented with linoleic acid or alpha-linolenic acid (substrates for FADS2). The study hypothesizes that subjects will be more sensitive to the dietary modifications according to their genotype leading to more robust differences in serum FA profile, tissue inflammation and serum lipids.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 13, 2018
CompletedFirst Posted
Study publicly available on registry
June 28, 2018
CompletedStudy Start
First participant enrolled
August 13, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 19, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 19, 2018
CompletedApril 18, 2019
April 1, 2019
4 months
June 13, 2018
April 17, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in fatty acid composition of serum lipid fractions
Fatty acid composition of serum lipid fractions
8 weeks
Secondary Outcomes (3)
Glucose and insulin metabolism response
8 weeks
Inflammatory markers response
8 weeks
Adipose tissue biopsies
8 weeks
Study Arms (4)
CC genotype LA
EXPERIMENTAL4-week study diet will be isocaloric following the habitual diet of the participants with a supplement of 30-50 ml (5-6 % of energy intake) of sunflower oil (source of LA: linoleic acid) daily, depending on body weight. The same diet will be instructed for both genotypes.
TT genotype LA
EXPERIMENTAL4-week study diet will be isocaloric following the habitual diet of the participants with a supplement of 30-50 ml (5-6 % of energy intake) of sunflower oil (source of LA: linoleic acid) daily, depending on body weight. The same diet will be instructed for both genotypes.
CC genotype ALA
EXPERIMENTAL4-week study diet will be isocaloric following the habitual diet of the participants with a supplement of 30-50 ml (5-6 % of energy intake) of camelina oil (source of alpha-linolenic acid: ALA) daily, depending on body weight. The same diet will be instructed for both genotypes.
TT genotype ALA
EXPERIMENTAL4-week study diet will be isocaloric following the habitual diet of the participants with a supplement of 30-50 ml (5-6 % of energy intake) of camelina oil (source of alpha-linolenic acid: ALA) daily, depending on body weight. The same diet will be instructed for both genotypes.
Interventions
The source of linoleic acid (LA) will be sunflower oil (62-63 % LA). The study diets will be isocaloric. The allowed weight change during the study is ± 2-3 %. The amount of supplementary oil will be calculated individually based on the calculated energy expenditure and adjusted, if necessary, during the study based on body weight measurements.
The source of alpha-linolenic acid (ALA) will be camelina sativa oil (30-35 % ALA). The study diets will be isocaloric. The allowed weight change during the study is ± 2-3 %. The amount of supplementary oil will be calculated individually based on the calculated energy expenditure and adjusted, if necessary, during the study based on body weight measurements.
Eligibility Criteria
You may qualify if:
- Participants of METSIM study cohort with CC/TT FADS1 rs174547 SNP genotype.
- BMI 20-32 kg/m2.
- Healthy .
You may not qualify if:
- Diagnosis of type 2 diabetes.
- Diagnosis of chronic diseases and conditions, that may hamper the ability to follow the dietary intervention protocol
- Chronic liver, thyroid and kidney diseases
- Alcohol abuse (\> 40 g/d)
- BMI \>32 kg/m2.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Eastern Finland
Kuopio, 70211, Finland
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jussi Pihlajamäki, MD
University of Eastern Finland
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 13, 2018
First Posted
June 28, 2018
Study Start
August 13, 2018
Primary Completion
December 19, 2018
Study Completion
December 19, 2018
Last Updated
April 18, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will not share